Muthusamy Shanmugam - Net Worth and Insider Trading

Muthusamy Shanmugam Net Worth

The estimated net worth of Muthusamy Shanmugam is at least $57 Million dollars as of 2024-05-03. Muthusamy Shanmugam is the HEAD OF R&D, COO-NOVITIUM OPS of ANI Pharmaceuticals Inc and owns about 856,272 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $57 Million. Details can be seen in Muthusamy Shanmugam's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Muthusamy Shanmugam has not made any transactions after 2024-04-19 and currently still holds the listed stock(s).

Transaction Summary of Muthusamy Shanmugam

To

Muthusamy Shanmugam Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Muthusamy Shanmugam owns 1 companies in total, including ANI Pharmaceuticals Inc (ANIP) .

Click here to see the complete history of Muthusamy Shanmugam’s form 4 insider trades.

Insider Ownership Summary of Muthusamy Shanmugam

Ticker Comapny Transaction Date Type of Owner
ANIP ANI Pharmaceuticals Inc 2024-04-19 director & HEAD OF R&D & COO-NOVITIUM OPS

Muthusamy Shanmugam Latest Holdings Summary

Muthusamy Shanmugam currently owns a total of 1 stock. Muthusamy Shanmugam owns 856,272 shares of ANI Pharmaceuticals Inc (ANIP) as of April 19, 2024, with a value of $57 Million.

Latest Holdings of Muthusamy Shanmugam

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIP ANI Pharmaceuticals Inc 2024-04-19 856,272 67.07 57,430,163

Holding Weightings of Muthusamy Shanmugam


Muthusamy Shanmugam Form 4 Trading Tracker

According to the SEC Form 4 filings, Muthusamy Shanmugam has made a total of 20 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 1 buys and 19 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 27,232 shares on April 19, 2024, which brought Muthusamy Shanmugam around $2 Million.

Insider Trading History of Muthusamy Shanmugam

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Muthusamy Shanmugam Trading Performance

GuruFocus tracks the stock performance after each of Muthusamy Shanmugam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Muthusamy Shanmugam is -13.91%. GuruFocus also compares Muthusamy Shanmugam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Muthusamy Shanmugam within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Muthusamy Shanmugam's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Muthusamy Shanmugam

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.56
Relative Return to S&P 500(%) 13.99

Muthusamy Shanmugam Ownership Network

Ownership Network List of Muthusamy Shanmugam

No Data

Ownership Network Relation of Muthusamy Shanmugam


Muthusamy Shanmugam Owned Company Details

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Muthusamy Shanmugam is the director & HEAD OF R&D & COO-NOVITIUM OPS of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , SVP - CORP. DEV. & STRATEGY Chad Gassert , and Vice President and CFO Stephen P. Carey .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Muthusamy Shanmugam made 19 insider transaction in ANI Pharmaceuticals Inc (ANIP) with a net sale of 626,190. Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 140,000 shares made by Chad Gassert , a net sale of 1,500 shares made by Meredith Cook , and a net sale of 400,000 shares made by Meridian Venture Partners Ii Lp .

In summary, during the past 3 months, insiders sold 230,132 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 230,132 shares. During the past 18 months, 1,371,108 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,371,108 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

Muthusamy Shanmugam Mailing Address

Above is the net worth, insider trading, and ownership report for Muthusamy Shanmugam. You might contact Muthusamy Shanmugam via mailing address: C/o Ani Pharmaceuticals, Inc., 210 Main Street West, Baudette Mn 56623.

Discussions on Muthusamy Shanmugam

No discussions yet.